California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.
MassDevice Earnings Roundup
Legal win, buyouts boost Bard’s bottom line
A nearly $900 million award from W.L. Gore boosted C.R. Bard’s bottom line in Q4 as sales inch up 3% in 2013: Officials announce $500 million share buyback plan.
Accuray soars on Street-beating Q2 and increased guidance
Cardiovascular Systems surges on Q2 results, outlook
Cardiovascular Systems (NSDQ:CSII) shares surged nearly 20% today on better-than-expected fiscal 2nd-quarter numbers and a 3rd-quarter outlook that came out well ahead of Wall Street’s forecast.
Zimmer’s Q4 profits surge
Abiomed hits record highs in Q3 with Impella sales up 20%
Siemens soars but healthcare biz takes a hit
Philips Healthcare’s Q4, 2013 profits rise despite lower sales
Philips Healthcare (NYSE:PHG) saw its profits rise at significant double-digit clip during the 4th quarter and 2013, despite declining sales.
SpineVision posts 27% sales boost in 2013
French spinal surgery devices maker SpineVision posted a strong fiscal 2013, with a doubling in product sales due in part to impressive growth in the U.S.
SpineVision reported doubled U.S. sales of its U.L.I.S. universal pedicle anchorage screws and LUMIS minimally invasive lumbar system.
Haemonetics’ streamlining efforts boost Q3 profits by 64%
Massachusetts medical device maker Haemonetics (NYSE:HAE) this week released its 3rd-quarter earnings report, posting a major boost in profits that the company attributed to "productivity programs yielding cost efficiencies."